(3S,4R)-PF-6683324

• UNSPSC Description:

  (3S,4R)-PF-6683324 is a tropomyosin-related kinase (Trk) inhibitor extracted from patent WO2015092610A1 example 9. (3S,4R)-PF-6683324 has the potential for the research of pain and cancer[1].

• Target Antigen:

  Trk Receptor

• Type:

  Reference compound

• Related Pathways:

  Neuronal Signaling;Protein Tyrosine Kinase/RTK

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer; Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/3s-4r-pf-6683324.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(N)C1=C(O[C@@H]2CCN(C(CC3=CC=C(OC(F)(F)F)C=C3)=O)C[C@@H]2F)N=CC(C4=CN(C)C=N4)=C1

• Molecular Weight:

  521.46

• References & Citations:

  [1]Skerratt SE, et, al. N-acylpiperidine ether tropomyosin-related kinase inhibitors. WO2015092610A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1799789-00-6